AstraZeneca's Covid-19 vaccine well tolerated and immunogenic in kids aged 6-17 years: Lancet study

The study was done between February 15 and April 2, 2021, with 262 participants aged 12-17 years.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/TdDf2ny
via IFTTT